Ledger.Open graph →
SEC Form D · filed April 17, 2024

Exsilio Therapeutics Inc

Offering
$85.0M
Sold
$38.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Henry Chen · Mountain View, CADirectorDylan Morris · San Fransicso, CADirectorTal Zaks, M.D., Ph.D · New York, NYDirectorAlex Harding · New York, NYDirectorAnat Nursella · New York, NYExecStephen Squinto · Woodbridge, CTDirectorRoy Amariglio · New York, NYExec · DirectorAaron Nelson · Sheridan, WYDirectorDylan Morris · Palo Alto, CADirectorHenry Chen · Sunnyvale, CADirectorTal Zaks, M.D., Ph.D · New York, NYDirectorAlex Harding · New York, NYDirectorAnat Nursella · New York, NYExecStephen Squinto · HANOVER, NHDirectorRoy Amariglio · New York, NYExec · DirectorAaron Nelson · Sheridan, WYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗